ABCG2 and cancer: In contrast to specific inhibitors targeting a single efflux pump, this ATP depletion simultaneously inactivates all ABC transporters expressed in cancer cells, preventing the efflux of antitumor drugs and potentiating their cytotoxic effect on the cell [171].